SCHEMBL5658742

SCHEMBL5658742

COc1cc(CO)c2cc(CN3CCOCC3)oc2c1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.41
HTT P42858 3/20 0.41
KDM4E B2RXH2 3/20 0.41
TP53 P04637 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
JAK2 O60674 1/20 0.41
JAK1 P23458 1/20 0.41
TYK2 P29597 1/20 0.41
JAK3 P52333 1/20 0.41
MITF O75030 1/20 0.41
LMNA P02545 1/20 0.41
ALOX15 P16050 1/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
SYK P43405 1/20 0.40
ALDH1A1 P00352 3/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.38
HPGD P15428 1/20 0.38
DRD2 P14416 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5659231 0.81 HTT (0.39) MAPTHTTKDM4ETP53LMNA
SCHEMBL5660063 0.80 POLB (0.55) MAPTHTTKDM4EALDH1A1DRD2
SCHEMBL5657873 0.78 DHFR (0.48) ALDH1A1TSHRHSD17B10
SCHEMBL5659063 0.77 NPC1 (0.38) MAPTHTTKDM4ETP53SMN1; SMN2
SCHEMBL5659067 0.77 NPC1 (0.38) MAPTHTTKDM4ETP53SMN1; SMN2
SCHEMBL18419263 0.76 HTT (0.52) MAPTHTTTP53SMN1; SMN2ALDH1A1
SCHEMBL5656011 0.75 MCL1 (0.39) MAPTKDM4EALDH1A1
SCHEMBL5656669 0.72 KDM4E (0.46) HTTKDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL5659220 0.71 TUBB4A (0.43) MAPTMAPK1ALDH1A1
SCHEMBL5659886 0.71 GPR55 (0.46) HTTKDM4ESMN1; SMN2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030130-B2 Benzofuran derivatives and their use as antibacterial agents ARPIDA AG (CH) 2006-04-18 US disclosed
EP-1307445-B1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2005-12-21 EP disclosed
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents EVOLVA SA (CH) 2004-02-19 US disclosed
EP-1307445-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS Arpida AG, (CH) 2003-05-07 EP disclosed
WO-2002010157-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2002-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents SBDS, BPTF, DCXR MAPT 3343/4885HTT 3152/4885KDM4E 1540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.